What is GLP-1 therapy?
GLP-1 therapy refers to medications that mimic or influence glucagon-like peptide-1 pathways involved in appetite, fullness, and metabolic regulation. Medications in this category include semaglutide products such as Wegovy and Ozempic. At Wellington Orthopedic Institute, GLP-1 treatment is physician-supervised and begins with an evaluation of medical history, current medications, weight history, goals, contraindications, and whether medication is appropriate.
This is not an automated prescription program. Dr. Mikolajczak evaluates patients as individuals, discusses benefits and risks, and determines whether GLP-1 therapy, nutrition changes, activity planning, or another path is appropriate.
FDA criteria and published clinical trial data
FDA-approved chronic weight management indications generally include adults with BMI 30+ or BMI 27+ with at least one weight-related condition, depending on the medication label and individual evaluation. Published clinical trial data from the STEP-1 trial reported 14.9% mean weight loss with semaglutide 2.4 mg in the studied population. Individual results vary, and physician evaluation is required.
Telemedicine throughout Florida
Initial consultations for medical weight loss may be completed by telemedicine for appropriate Florida patients, with no office visit required for the initial consult. This can make evaluation more convenient while still keeping care physician-supervised.
Who qualifies?
Qualification depends on BMI, weight-related health conditions, medical history, medication safety, contraindications, goals, and physician judgment. GLP-1 therapy is for qualifying patients only and requires a medical evaluation before prescribing. It may not be appropriate for patients with certain histories or medication risks.
How it works at Wellington Orthopedic Institute
The process begins with a consultation, review of your health history, and discussion of goals. If you qualify, the plan may include medication selection, dosing guidance, nutrition and activity recommendations, monitoring, side-effect review, and follow-up. For orthopedic patients, weight loss may also support joint comfort and mobility goals, though results vary.
Disclaimers: GLP-1 medications are available for qualifying patients only. Physician evaluation is required. Medication availability, insurance coverage, compounded medication rules, and prescribing requirements can change. Results vary by individual.
Frequently asked questions
What is a GLP-1 medication?
GLP-1 medications influence appetite, fullness, and metabolic pathways. Semaglutide products include Wegovy and Ozempic, though medication choice depends on indication and physician evaluation.
Who qualifies for medical weight loss medication?
FDA-approved chronic weight management indications generally include BMI 30+ or BMI 27+ with a weight-related condition, depending on medication labeling and physician evaluation.
Is telemedicine available for GLP-1 consultations in Florida?
Yes. Initial consultations may be available by telemedicine throughout Florida for appropriate patients, with no office visit required for the initial consult.
How much weight loss is possible with semaglutide?
Published STEP-1 clinical trial data reported 14.9% mean weight loss with semaglutide 2.4 mg in the studied population. Individual results vary.
How do I book a GLP-1 doctor in Wellington, FL?
Call 561-670-2010 or use the online booking link to request a physician-supervised medical weight loss evaluation.